Nick Zdenkowski

9PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 09, 2023
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.

Georg Pfeiler, Dominik Hlauschek, Erica L Mayer

|Apr 07, 2022
What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis.

Yvonne L Luigjes-Huizer, Nina M Tauber, Gerry Humphris

|Jan 07, 2022
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).

Erica L Mayer, Christian Fesl, Dominik Hlauschek

|Oct 12, 2019
Results of a survey of cancer patients' willingness to travel to participate in a clinical trial.

Nicholas Zdenkowski, James Lynam, Victoria Sproule

|Apr 28, 2019
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311.

Stephen P Ackland, V Gebski, N Zdenkowski

|Feb 06, 2017
Treatment of pancreatic insufficiency using pancreatic extract in patients with advanced pancreatic cancer: a pilot study (PICNIC).

Nicholas Zdenkowski, George Radvan, Leanna Pugliese

Pageof 2

Frequent Collaborators

2 joint publications

Amylou Dueck

2 joint publications

Michael Gnant

2 joint publications

Fatima Cardoso

2 joint publications

Erica L Mayer